Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Efficacy and safety of aprepitant in patients with breast cancer].
Tagashira H, Matsuhisa T, Oze I, Kiyoto S, Takahashi M, Hara F, Takabatake D, Takashima S, Aogi K, Osumi S, Eguchi H. Tagashira H, et al. Among authors: osumi s. Gan To Kagaku Ryoho. 2011 Aug;38(8):1307-11. Gan To Kagaku Ryoho. 2011. PMID: 21829069 Japanese.
Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): an open-label, non-inferiority, randomised phase 3 trial.
Takashima T, Mukai H, Hara F, Matsubara N, Saito T, Takano T, Park Y, Toyama T, Hozumi Y, Tsurutani J, Imoto S, Watanabe T, Sagara Y, Nishimura R, Shimozuma K, Ohashi Y; SELECT BC Study Group. Takashima T, et al. Lancet Oncol. 2016 Jan;17(1):90-8. doi: 10.1016/S1470-2045(15)00411-8. Epub 2015 Nov 27. Lancet Oncol. 2016. PMID: 26617202 Clinical Trial.
The impact of neoadjuvant systemic therapy on breast conservation rates in patients with HER2-positive breast cancer: Surgical results from a phase II randomized controlled trial.
Yamaguchi T, Hozumi Y, Sagara Y, Takahashi M, Yoneyama K, Fujisawa T, Osumi S, Akabane H, Nishimura R, Mieno MN, Mukai H. Yamaguchi T, et al. Among authors: osumi s. Surg Oncol. 2021 Mar;36:51-55. doi: 10.1016/j.suronc.2020.11.008. Epub 2020 Nov 20. Surg Oncol. 2021. PMID: 33310293 Clinical Trial.
Identification of serum proteins related to adverse effects induced by docetaxel infusion from protein expression profiles of serum using SELDI ProteinChip system.
Heike Y, Hosokawa M, Osumi S, Fujii D, Aogi K, Takigawa N, Ida M, Tajiri H, Eguchi K, Shiwa M, Wakatabe R, Arikuni H, Takaue Y, Takashima S. Heike Y, et al. Among authors: osumi s. Anticancer Res. 2005 Mar-Apr;25(2B):1197-203. Anticancer Res. 2005. PMID: 15865066 Free article. Clinical Trial.
49 results